EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer

Diana-Theodora Morgos, Constantin Stefani, Daniela Miricescu, Maria Greabu, Silviu Stanciu, Silvia Nica iD, Iulia-Ioana Stanescu-Spinu, Daniela Gabriela Balan, Andra-Elena Balcangiu-Stroescu, Elena-Claudia Coculescu, Dragos-Eugen Georgescu iD, Remus Iulian Nica iD

International Journal of Molecular Sciences · 03.02.2024 · 25 (3) · 1848

DOI: 10.3390/ijms25031848 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2024. Verfasst von Diana-Theodora Morgos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Anatomy, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Stomach Neoplasms. Die Arbeit wurde bisher 195-mal zitiert (Crossref) und nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) is the fourth leading cause of death worldwide, with more than 1 million cases diagnosed every year. Helicobacter pylori represents the main risk factor, being responsible for 78% of the cases. Increased amounts of salt, pickled food, red meat, alcohol, smoked food, and refined sugars negatively affect the stomach wall, contributing to GC development. Several gene mutations, including PIK3CA, TP53, ARID1A, CDH1, Ras, Raf, and ERBB3 are encountered in GC pathogenesis, leading to phosphatidylinositol 3-kinase (PI3K) protein kinase B (AKT)/mammalian target of rapamycin (mTOR)—PI3K/AKT/mTOR—and mitogen-activated protein kinase (MAPK) signaling pathway activation and promoting tumoral activity. Helicobacter pylori, growth factors, cytokines, hormones, and oxidative stress also activate both pathways, enhancing GC development. In clinical trials, promising results have come from monoclonal antibodies such as trastuzumab and ramucirumab. Dual inhibitors targeting the PI3K/AKT/mTOR and MAPK signaling pathways were used in vitro studies, also with promising results. The main aim of this review is to present GC incidence and risk factors and the dysregulations of the two protein kinase complexes together with their specific inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktStomach NeoplasmsHumansPhosphatidylinositol 3-KinaseSirolimusPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesMAP Kinase Signaling System

Stichwörter der Autor:innen

MAPKPI3K/AKT/mTORbacterial infectiondysregulationgastric cancergene mutationsinhibitors

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinaseSirolimusPhosphatidylinositol 3-KinasesTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Discipline of Anatomy, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Department I of Family Medicine and Clinical Base, "Dr. Carol Davila" Central Military Emergency University Hospital, 010825 Bucharest, Romania.
  • Discipline of Biochemistry, Faculty of Dentistry, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Department of Internal Medicine and Gastroenterology, Carol Davila University of Medicine and Pharmacy, Central Military Emergency University Hospital, 010825 Bucharest, Romania.
  • Emergency Discipline, University Hospital of Bucharest, 050098 Bucharest, Romania.
  • Discipline of Physiology, Faculty of Dentistry, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

ORCID-Profile: Silvia Nica, Dragos-Eugen Georgescu, Remus Iulian Nica

Zitieren

APA

Morgos, D. T., Stefani, C., Miricescu, D., Greabu, M., Stanciu, S., Nica, S., Stanescu-Spinu, I. I., Balan, D. G., Balcangiu-Stroescu, A. E., Coculescu, E. C., Georgescu, D. E., & Nica, R. I. (2024). Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer. International Journal of Molecular Sciences, 25(3), 1848. https://doi.org/10.3390/ijms25031848

Vancouver

Morgos DT, Stefani C, Miricescu D, Greabu M, Stanciu S, Nica S, et al. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer. International Journal of Molecular Sciences. 2024;25(3):1848. doi:10.3390/ijms25031848

BibTeX
@article{Morgos2024,
  author = {Morgos, Diana-Theodora and Stefani, Constantin and Miricescu, Daniela and Greabu, Maria and Stanciu, Silviu and Nica, Silvia and Stanescu-Spinu, Iulia-Ioana and Balan, Daniela Gabriela and Balcangiu-Stroescu, Andra-Elena and Coculescu, Elena-Claudia and Georgescu, Dragos-Eugen and Nica, Remus Iulian},
  title = {Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {1848},
  doi = {10.3390/ijms25031848}
}
Kostenlos starten →